Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes

(2013) Allison B. Goldfine   ANNALS OF INTERNAL MEDICINE

Muscles, exercise and obesity: skeletal muscle as a secretory organ

(2012) Bente K. Pedersen et al.   Nature Reviews Endocrinology

CD14 Modulates Inflammation-Driven Insulin Resistance

(2011) J. M. Fernandez-Real et al.   DIABETES

Fractalkine: A Cellular Link Between Adipose Tissue Inflammation and Vascular Pathologies

(2011) W. T. Cefalu   DIABETES

Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics

(2011) Alla Khashper et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

(2011) Ralph A. DeFronzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thiazolidinedione Drugs and Cardiovascular Risks

(2010) Sanjay Kaul et al.   CIRCULATION

Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

(2010) Giovanni Anfossi et al.   MEDIATORS OF INFLAMMATION

Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005

(2009) Sarah Rosner Preis et al.   CIRCULATION

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes

(2009) Yoshimasa Aso et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans

(2009) A. Monroy et al.   DIABETOLOGIA

Comparative Study of Low-dose Pioglitazone or Metformin Treatment in Japanese Diabetic Patients with Metabolic Syndrome

(2009) T. Kato et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Rosiglitazone activation of PPARγ suppresses fractalkine signaling

(2009) Yihong Wan et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

siRNA-Mediated Reduction of Inhibitor of Nuclear Factor- B Kinase Prevents Tumor Necrosis Factor- -Induced Insulin Resistance in Human Skeletal Muscle

(2008) R. L. Austin et al.   DIABETES

Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2 −/− Mice

(2007) Noah Saederup et al.   CIRCULATION